CRL
Price
$157.12
Change
-$0.37 (-0.23%)
Updated
Jul 3 closing price
Capitalization
13.96B
25 days until earnings call
TWST
Price
$38.17
Change
+$0.49 (+1.30%)
Updated
Jul 3 closing price
Capitalization
1.98B
27 days until earnings call
Interact to see
Advertisement

CRL vs TWST

Header iconCRL vs TWST Comparison
Open Charts CRL vs TWSTBanner chart's image
Charles River Laboratories International
Price$157.12
Change-$0.37 (-0.23%)
Volume$247.09K
Capitalization13.96B
Twist Bioscience
Price$38.17
Change+$0.49 (+1.30%)
Volume$445.33K
Capitalization1.98B
CRL vs TWST Comparison Chart in %
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. TWST commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and TWST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (CRL: $157.12 vs. TWST: $38.17)
Brand notoriety: CRL and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 24% vs. TWST: 39%
Market capitalization -- CRL: $13.96B vs. TWST: $1.98B
CRL [@Medical Specialties] is valued at $13.96B. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRL and TWST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 4 TA indicator(s) are bullish while TWST’s TA Score has 6 bullish TA indicator(s).

  • CRL’s TA Score: 4 bullish, 3 bearish.
  • TWST’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TWST is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а +3.65% price change this week, while TWST (@Medical Specialties) price change was +3.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

CRL is expected to report earnings on Jul 30, 2025.

TWST is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than TWST($1.98B). CRL YTD gains are higher at: -14.886 vs. TWST (-17.861). CRL has higher annual earnings (EBITDA): 1.03B vs. TWST (-172.41M). TWST has more cash in the bank: 311M vs. CRL (277M). TWST has less debt than CRL: TWST (91.9M) vs CRL (3.07B). CRL has higher revenues than TWST: CRL (4.13B) vs TWST (262M).
CRLTWSTCRL / TWST
Capitalization14B1.98B706%
EBITDA1.03B-172.41M-599%
Gain YTD-14.886-17.86183%
P/E Ratio29.15N/A-
Revenue4.13B262M1,576%
Total Cash277M311M89%
Total Debt3.07B91.9M3,336%
FUNDAMENTALS RATINGS
CRL vs TWST: Fundamental Ratings
CRL
TWST
OUTLOOK RATING
1..100
4119
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9096
PRICE GROWTH RATING
1..100
5452
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (44) in the Biotechnology industry is somewhat better than the same rating for CRL (96) in the Miscellaneous Commercial Services industry. This means that TWST’s stock grew somewhat faster than CRL’s over the last 12 months.

TWST's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as CRL (100) in the Miscellaneous Commercial Services industry. This means that TWST’s stock grew similarly to CRL’s over the last 12 months.

CRL's SMR Rating (90) in the Miscellaneous Commercial Services industry is in the same range as TWST (96) in the Biotechnology industry. This means that CRL’s stock grew similarly to TWST’s over the last 12 months.

TWST's Price Growth Rating (52) in the Biotechnology industry is in the same range as CRL (54) in the Miscellaneous Commercial Services industry. This means that TWST’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is significantly better than the same rating for TWST (100) in the Biotechnology industry. This means that CRL’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLTWST
RSI
ODDS (%)
Bearish Trend 3 days ago
56%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EFIV59.270.71
+1.21%
SPDR® S&P 500® ESG ETF
MVPA34.740.19
+0.56%
Miller Value Ptnrs Appreciation ETF
SVXY42.820.13
+0.30%
ProShares Short VIX Short-Term Futures
AUGM32.970.05
+0.16%
FT Vest U.S. Eq Max Buffr ETF - Aug
NBCC27.52N/A
N/A
Neuberger Berman Nxt Gen Cnnctd Cnsm ETF

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-0.23%
IQV - CRL
73%
Closely correlated
-0.25%
RVTY - CRL
62%
Loosely correlated
+0.41%
A - CRL
59%
Loosely correlated
+0.60%
NOTV - CRL
58%
Loosely correlated
+3.21%
MEDP - CRL
57%
Loosely correlated
+0.14%
More